|
|
Publications
| |
Author |
Details |
Date |
|
Ann M. Thayer | Improving Peptides - Small firms develop better peptide drug candidates to expand this pharmaceutical class and attract big pharma partners. http://pubs.acs.org/cen/coverstory/89/8922cover.html | 18-07-2011 |
|
Ngoei, K., Catimel, B., Church., N., Lio., Dogovski., Perugini, M., Watt., P., Cheng, HC., Ng, DC Bo | Characterization of a novel c-Jun N-terminal Kinase (JNK) inhibitory peptide., Biochem J. 24;434(3):399-413 | 07-04-2011 |
|
Meade, A.J., Meloni, B., Mastaglia, F., Watt, P. and Knuckey, N. (2010) | AP-1 inhibitory peptides attenuate in vitro cortical neuronal cell death induced by kainic acid. Brain Research 1360: 8-16 | 07-04-2011 |
|
Meade AJ, Meloni BP, Mastaglia FL, Watt PM, Knuckey NW (2010) | Attenuation of neuronal death by peptide inhibitors of AP-1 activation in acute and delayed in vitro ischaemia (oxygen/glucose deprivation) models. International Journal of Peptide Research and Therapeutics. Volume 17, (1), 1-6, | 07-04-2011 |
|
 |